[
  {
    "pdf": "scihub_s00381-021-05138-3.pdf_3",
    "image_path": "scihub_s00381-021-05138-3.pdf_3.pdf_0.jpg",
    "page_idx": 0,
    "category_type": "figure_caption",
    "bbox_norm": null,
    "text": "**Table 1** PLGG with KIAA1549-BRAF fusion: patient characteristics, response, and toxicity with trametinib",
    "html": ""
  },
  {
    "pdf": "scihub_s00381-021-05138-3.pdf_3",
    "image_path": "scihub_s00381-021-05138-3.pdf_3.pdf_0.jpg",
    "page_idx": 0,
    "category_type": "table",
    "bbox_norm": null,
    "text": "",
    "html": "<table><thead><tr><th>Cases</th><th>Age at diagnosis<br>(years); sex</th><th>Histologic diagnosis;<br>tumor location</th><th>Prior<br>surgery</th><th>Prior therapy</th><th>Age on treatment<br>onset (years)</th><th>Time on<br>treatment<br>(months)</th><th>Best overall<br>response</th><th>Functional<br>response</th><th>Side effects</th></tr></thead><tbody><tr><td>Case 1</td><td>1.5; F</td><td>PA; medulla oblongata<br>with leptomeningeal<br>dissemination</td><td>Biopsy</td><td>CPT 11-CDDP; VBL</td><td>5.8</td><td>20</td><td>PR</td><td>Stable</td><td>Skin (grade II)<br>Abdominal pain (grade II)<br>Cheilitis (grade I)<br>CPK and AP increased<br>(grade I)</td></tr><tr><td>Case 2</td><td>0.5; M</td><td>PMA; hypothalamic-<br>chiasmatic</td><td>Biopsy, PR</td><td>VCR-CBCDA; 5<br>DR-BEV</td><td>1</td><td>18</td><td>SD</td><td>Stable</td><td>Skin (grade I)<br>Cheilitis (grade I)</td></tr><tr><td>Case 3</td><td>0.9; F</td><td>PA; intramedullary</td><td>Biopsy</td><td>VCR-CBCDA; CPT<br>11-CDDP</td><td>12</td><td>15</td><td>SD</td><td>Improvement of brachial<br>hemiparesis, resolution<br>of paresthesia in hands<br>and torticollis</td><td>Alopecia (grade I)<br>Vasculitis (grade III)<br>CPK and ALT increased<br>(grade I)</td></tr><tr><td>Case 4</td><td>1; M</td><td>PMA; hypothalamic-<br>chiasmatic</td><td>Biopsy</td><td>CPT 11-CDDP; VBL;<br>BEV-CDDP; BEV</td><td>7.5</td><td>5</td><td>SD</td><td>Stable</td><td>Skin (grade II)<br>Cheilitis (grade I)<br>Mucositis oral (grade I)<br>Abdominal pain (grade I)<br>Fatigue and anorexia (grade<br>II)</td></tr><tr><td>Case 5</td><td>4.4; F</td><td>PA; hypothalamic-<br>chiasmatic</td><td>Biopsy, PR</td><td>CPT 11-CDDP; VBL;<br>BEV-CDDP</td><td>12.5</td><td>8</td><td>PD</td><td>Visual deterioration</td><td>Skin (grade II)<br>Alopecia (grade II)<br>Cheilitis (grade III)<br>Mucositis oral (grade II)<br>Fatigue and anorexia (grade<br>II)</td></tr><tr><td>Case 6</td><td>5.8; F</td><td>PA; intramedullary</td><td>Biopsy, PR</td><td>CPT 11-CDDP; VBL;<br>BEV-CDDP</td><td>12.3</td><td>15</td><td>SD</td><td>Resolution of<br>paresthesia in hands</td><td>Skin (grade I)<br>Alopecia (grade I)<br>Mucositis oral (grade I)<br>CPK and LDH increased<br>(grade I)</td></tr><tr><td>Case 7</td><td>0.8; F</td><td>PMA; hypothalamic-<br>chiasmatic</td><td>Biopsy</td><td>VCR-CBCDA; BEV</td><td>2.8</td><td>6</td><td>PD</td><td>Stable</td><td>Skin (grade II)<br>Alopecia (grade I)<br>Abdominal pain (grade I)</td></tr><tr><td>Case 8</td><td>1.8; M</td><td>PAs; hypothalamic-<br>chiasmatic</td><td>Biopsy</td><td>VCR-CBCDA; VBL</td><td>2.9</td><td>6</td><td>PD</td><td>Increased hemiparesis<br>and cranial nerve<br>abnormalities</td><td>Skin (grade I)</td></tr><tr><td>Case 9</td><td>3.9; M</td><td>PA; hypothalamic-<br>chiasmatic with<br>leptomeningeal<br>dissemination</td><td>PR</td><td>CPT 11-CDDP</td><td>9.6</td><td>14 (continue)</td><td>SD</td><td>Stable</td><td>Skin (grade II)<br>Abdominal pain (grade I)<br>CPK increased (grade II)<br>AST and LDH increased<br>(grade I)</td></tr><tr><td>Case 10</td><td>0.4; M</td><td>PMA; hypothalamic-<br>chiasmatic</td><td>Biopsy, PR</td><td>VCR-CBCDA; VBL-BEV</td><td>1.8</td><td>14 (continue)</td><td>SD</td><td>Diencephalic syndrome<br>improvement</td><td>Skin (grade II)<br>Abdominal pain (grade II)<br>Vomiting (grade I)<br>CPK increased (grade II)</td></tr><tr><td>Case 11</td><td>1.1; F</td><td>GG; intramedullary</td><td>Biopsy, PR</td><td>CPT 11-CDDP; VBL;<br>VCR-CBCDA;<br>BEV-CPT 11</td><td>10.8</td><td>12 (continue)</td><td>SD</td><td>Stable</td><td>Skin (grade I)<br>Cystitis (grade II)<br>Lymph gland infection<br>(grade III)<br>LDH increased (grade I)</td></tr></tbody></table>"
  }
]